A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...

Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

The company emphasised that it is ready to meet the growing demand for drug-device combinations and biologics, with ...

Alzheimer's disease Therapeutics Market. LAS VEGAS, NV, UNITED STATES, January 23, 2025 /EINPresswire / -- DelveInsight's“Acute Respiratory Distress Synd ...

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

A Georgia woman who lost 60 pounds taking semaglutide spent nearly $20,000 on a 'mommy makeover' only to pile the weight back ...

Lexaria Bioscience Corp., a global innovator in drug delivery platforms, has announced partial final results showcasing the ...

More than one-third of websites selling their own versions implied the products were the same as the FDA-approved drugs.

Whenever a new year begins, most of us strive to make some resolutions such as going to the gym, drinking less (aka, Sober ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.